Cellular Prion Protein Mediates the Toxicity of β-Amyloid OligomersImplications for Alzheimer Disease
Haakon B. Nygaard, MD;
Stephen M. Strittmatter, MD, PhD
Arch Neurol. 2009;66(11):1325-1328.
Alzheimer disease (AD) is the most common cause of age-related dementia, affecting more than 25 million people worldwide. The accumulation of insoluble β-amyloid (Aβ) plaques in the brain has long been considered central to the pathogenesis of AD. However, recent evidence suggests that soluble oligomeric assemblies of Aβ may be of greater importance. β-Amyloid oligomers have been found to be potent synaptotoxins, but the mechanism by which they exert their action has remained elusive. Herein, we review the recently published finding that cellular prion protein (PrPc) is a high-affinity receptor for Aβ oligomers, mediating their toxic effects on synaptic plasticity. We further discuss the relationship between AD and PrPc and the potential clinical implications. Cellular prion protein may provide a novel target for therapeutic intervention in AD.
Author Affiliations: Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, Connecticut.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
This Month in Archives of Neurology
Arch Neurol. 2009;66(11):1320-1321.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
{alpha}-Secretase-derived Fragment of Cellular Prion, N1, Protects against Monomeric and Oligomeric Amyloid {beta} (A{beta})-associated Cell Death
Guillot-Sestier et al.
J. Biol. Chem. 2012;287:5021-5032.
ABSTRACT
| FULL TEXT
The Prion Diseases
Brown and Mastrianni
J Geriatr Psychiatry Neurol 2010;23:277-298.
ABSTRACT
|
